학술논문
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
Document Type
Article
Author
Distler, Oliver ; Allanore, Yannick; Denton, Christopher P; Kuwana, Masataka; Matucci-Cerinic, Marco; Pope, Janet E; Atsumi, Tatsuya; Bečvář, Radim; Czirják, László; Hachulla, Eric; Ishii, Tomonori; Ishikawa, Osamu; Johnson, Sindhu R; De Langhe, Ellen; Stagnaro, Chiara; Riccieri, Valeria; Schiopu, Elena; Silver, Richard M; Smith, Vanessa; Steen, Virginia; Stevens, Wendy; Szücs, Gabriella; Truchetet, Marie-Elise; Wosnitza, Melanie; Laapas, Kaisa; Kramer, Frank; Khanna, Dinesh
Source
In The Lancet Rheumatology November 2023 5(11):e660-e669
Subject
Language
ISSN
2665-9913